SCHEMBL4032915

SCHEMBL4032915

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)O)CC2)nc2ccccc12

nearest known ligand 0.74

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 19/20 0.74
ADRA2A P08913 18/20 0.74
NPY5R Q15761 5/20 0.69
HTR1A P08908 1/20 0.69
ADRA1A P35348 1/20 0.69
HRH1 P35367 1/20 0.69
HTR2B P41595 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4032911 1.00 MCHR1 (0.74) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL13793460 0.92 MCHR1 (0.72) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL4207614 0.91 MCHR1 (0.70) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL30454842 0.90 MCHR1 (0.67) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL13793876 0.90 MCHR1 (0.69) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL5521004 0.90 MCHR1 (0.69) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL5521010 0.90 MCHR1 (0.69) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL13793034 0.90 MCHR1 (0.86) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL13793468 0.89 MCHR1 (0.68) MCHR1ADRA2ANPY5RHTR1AADRA1A
SCHEMBL5527360 0.89 MCHR1 (0.68) MCHR1ADRA2ANPY5RHTR1AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611109-A4 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO LTD (JP) 2009-06-24 EP disclosed
EP-1611109-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-01-04 EP disclosed
WO-2004087680-A1 NOVEL QUINAZOLINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO., LTD. (JP) 2004-10-14 WO disclosed